Video Experimental Relacionado
Updated: Jul 10, 2026
07:53
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Un análogo de bisfosfonato monoamida de DOTA: un agente potencial para la orientación ósea
Vojtech Kubícek1, Jakub Rudovský, Jan Kotek
1Laboratory of Organic Chemistry and Catalysis, Delft University of Technology, Julianalaan 136, 2628 BL Delft, The Netherlands.
Journal of the American Chemical Society
|November 25, 2005
Resumen
Se desarrolló un nuevo ligando similar a DOTA, BPAMD, para la imagen y la terapia de orientación ósea. Su complejo Gd(III) muestra una fuerte unión a la hidroxiapatita, mejorando el potencial de contraste de la RM.
Área de la Ciencia:
- La radioquímica es la radioquímica.
- La medicina nuclear es una medicina nuclear.
- Ciencia de los materiales Ciencia de los materiales.
Sus antecedentes:
- El desarrollo de radiofármacos dirigidos para imágenes y terapia ósea es crucial.
- Los ligandos macrocíclicos como el DOTA son esenciales para la complejación estable de los lantánidos.
- Los agentes de búsqueda ósea son necesarios para administrar radionucleidos terapéuticos o sondas de imagen al tejido óseo.
Objetivo del estudio:
- Diseñar y sintetizar un nuevo ligando macrocíclico similar al DOTA (BPAMD) con un grupo de búsqueda ósea.
- Evaluar el potencial de los complejos lantánidos de BPAMD para imágenes óseas y terapia.
- Investigar el mecanismo de unión y la mejora de la relaxividad de Gd(III) -BPAMD en la hidroxiapatita.
Principales métodos:
- Síntesis y caracterización del ligando BPAMD y sus complejos lantánidos.
- Espectroscopia de RMN 1H y 31P para la caracterización compleja.
- 1H y 17O estudios relaxométricos y mediciones de 1H NMRD.
- Experimentos de sorción utilizando hidroxiapatita (HA) como modelo de hueso.
- Estudios radioquímicos con 160Tb-BPAMD.
Principales resultados:
- El complejo Gd(III) -BPAMD demostró una absorción efectiva y una fuerte unión a la hidroxiapatita.
- Los estudios de RMN confirmaron la interacción entre el complejo y la superficie mineral ósea.
- Se observó una mejora de la relaxividad tras la adsorción de Gd(III) -BPAMD en HA.
- La porción de amida-bis (((fosfonato) fue identificada como el grupo clave de unión ósea.
- Los estudios radioquímicos mostraron una sorción rápida, fuerte y reversible de 160Tb-BPAMD en HA.
Conclusiones:
- BPAMD es un ligando prometedor para el desarrollo de agentes dirigidos a los huesos.
- El grupo de la monoamida bis ((ácido fosfónico) se dirige eficazmente a la hidroxiapatita.
- Gd(III) -BPAMD muestra potencial como agente de contraste de resonancia magnética para imágenes óseas.
- El sistema de ligandos desarrollado es prometedor para la terapia de radionucleidos dirigida a los huesos.
Videos de Conceptos Relacionados
01:17Antidotes
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.